A solid quarterly earnings report reverberated though the pundit community that day.A bellwether stock in the lately rather up-and-down pharmaceutical sector, AbbVie (ABBV 3.28%) finished the trading week in style. The company's shares closed more than 3% higher in price thanks in no small part to a clutch of post-earnings analyst price-target increases. With that performance, Abbvie crushed the S&P 500 index, which dived by 1.6% on the day. A bullish stampedeAs typically happens when a publicly traded comp ...